Michael Schwenkert

800 total citations
14 papers, 673 citations indexed

About

Michael Schwenkert is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Michael Schwenkert has authored 14 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Michael Schwenkert's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Michael Schwenkert is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Michael Schwenkert collaborates with scholars based in Germany, United States and Netherlands. Michael Schwenkert's co-authors include Georg H. Fey, Christian Kellner, Bernhard Stockmeyer, Christoph Stein, Kristin Mentz, Domenica Saul, Jan Dörrie, Katrin Birkholz, Beatrice Schuler‐Thurner and Fuat Oduncu and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Cancer.

In The Last Decade

Michael Schwenkert

13 papers receiving 651 citations

Peers

Michael Schwenkert

IMMUN

ONCOL

RNMI

GENET

Patrick Engelberts Netherlands

Thies Rösner Germany

Rodrigo Vazquez-Lombardi Australia

Galit Denkberg Israel

Thomas Van Blarcom United States

Katja Klausz Germany

Matthias Leisegang Germany

Martin Treder Germany

Katrijn Broos Belgium

Zekui Wu United States

Patrick Engelberts Netherlands

Michael Schwenkert

412 ×1.0

IMMUN

286 ×0.8

ONCOL

227 ×0.9

414 ×1.9

RNMI

76 ×1.0

GENET

Citations per year, relative to Michael Schwenkert Michael Schwenkert (= 1×) peers Patrick Engelberts

Countries citing papers authored by Michael Schwenkert

Since Specialization

Citations

This map shows the geographic impact of Michael Schwenkert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schwenkert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schwenkert more than expected).

Fields of papers citing papers by Michael Schwenkert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schwenkert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schwenkert. The network helps show where Michael Schwenkert may publish in the future.

Co-authorship network of co-authors of Michael Schwenkert

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schwenkert. A scholar is included among the top collaborators of Michael Schwenkert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schwenkert. Michael Schwenkert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lallemand, Christophe, et al.. (2025). Advanced assay platform for antibody development: Precision assays for ADCC, ADCP, and CDC. Immunobiology. 230(4). 152948–152948.

Mladenov, Radoslav, Anh‐Tuan Pham, Dmitrij Hristodorov, et al.. (2016). A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein. International Journal of Cancer. 139(4). 916–927. 29 indexed citations

Birkholz, Katrin, Alexander Paulus, Michael Schwenkert, et al.. (2015). Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone. Cancer Immunology Immunotherapy. 64(12). 1623–1635. 41 indexed citations

Kneissl, Sabrina, Qi Zhou, Michael Schwenkert, et al.. (2013). CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes. PLoS ONE. 8(11). e79047–e79047. 24 indexed citations

Schubert, Ingo, Christian Kellner, Christoph Stein, et al.. (2012). A recombinant triplebody with specificity for CD19 and HLA-DR mediates  preferential binding to antigen double-positive cells by dual-targeting. mAbs. 4(1). 45–56. 27 indexed citations

Schubert, Ingo, Christian Kellner, Christoph Stein, et al.. (2011). A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting. mAbs. 3(1). 21–30. 47 indexed citations

Kellner, Christian, Joerg Bruenke, Jöerg Schubert, et al.. (2011). Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells. Cancer Letters. 303(2). 128–139. 39 indexed citations

Bruyn, Marco de, Anna A. Rybczynska, Yunwei Wei, et al.. (2010). Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo. Molecular Cancer. 9(1). 301–301. 60 indexed citations

Stein, Christoph, Christian Kellner, Kristin Mentz, et al.. (2010). A recombinant trispecific single‐chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting. British Journal of Haematology. 150(5). 574–586. 111 indexed citations

10.

Stein, Christoph, Christian Kellner, Kristin Mentz, et al.. (2010). Novel conjugates of single‐chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells. British Journal of Haematology. 148(6). 879–889. 61 indexed citations

11.

Birkholz, Katrin, Michael Schwenkert, Christian Kellner, et al.. (2010). Targeting of DEC-205 on human dendritic cells results in efficient MHC class II–restricted antigen presentation. Blood. 116(13). 2277–2285. 110 indexed citations

12.

Stein, Christoph, Michael Schwenkert, Domenica Saul, et al.. (2009). Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework. Protein Engineering Design and Selection. 22(3). 135–147. 44 indexed citations

13.

Kellner, Christian, Joerg Bruenke, Julia Stieglmaier, et al.. (2008). A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells. Journal of Immunotherapy. 31(9). 871–884. 62 indexed citations

14.

Schwenkert, Michael, Katrin Birkholz, Christian Kellner, et al.. (2008). A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells. Melanoma Research. 18(2). 73–84. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact